The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process
Jonathan R. K. Stroud
Part of the Health Law and Policy Commons
Part of the Health Law and Policy Commons
The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process
Jonathan R. K. Stroud